
Edward M. Johnson
Examiner (ID: 7890, Phone: (571)272-1352 , Office: P/1736 )
| Most Active Art Unit | 1736 |
| Art Unit(s) | 1736, 1754, 1793 |
| Total Applications | 2442 |
| Issued Applications | 1938 |
| Pending Applications | 144 |
| Abandoned Applications | 375 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18718103
[patent_doc_number] => 11795438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Composition for promoting proliferation of pluripotent stem cells, and method for promoting proliferation of pluripotent stem cells
[patent_app_type] => utility
[patent_app_number] => 16/471312
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4178
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471312 | Composition for promoting proliferation of pluripotent stem cells, and method for promoting proliferation of pluripotent stem cells | Dec 18, 2017 | Issued |
Array
(
[id] => 15619297
[patent_doc_number] => 20200080053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => USE OF PEPTIDE COMPOUNDS FOR PROMOTING SURVIVAL, GROWTH AND CELL DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 16/466177
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466177 | Use of peptide compounds for promoting survival, growth and cell differentiation | Dec 4, 2017 | Issued |
Array
(
[id] => 17135021
[patent_doc_number] => 11136567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => CRISPR/CPF1 systems and methods
[patent_app_type] => utility
[patent_app_number] => 15/821736
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17347
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821736 | CRISPR/CPF1 systems and methods | Nov 21, 2017 | Issued |
Array
(
[id] => 15254565
[patent_doc_number] => 20190376016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => PERSONALIZED CELLULAR BIOMANUFACTURING WITH A CLOSED, MINIATURE CELL CULTURE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/462753
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462753
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462753 | PERSONALIZED CELLULAR BIOMANUFACTURING WITH A CLOSED, MINIATURE CELL CULTURE SYSTEM | Nov 21, 2017 | Abandoned |
Array
(
[id] => 15210371
[patent_doc_number] => 20190367872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => ORGANOID TISSUE ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 16/462313
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462313
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462313 | Organoid tissue engineering | Nov 16, 2017 | Issued |
Array
(
[id] => 15646699
[patent_doc_number] => 20200085879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => METHOD FOR EFFICIENTLY PRODUCING 3D MIDBRAIN-LIKE ORGANOID THROUGH SPECIFIC ELECTROMAGNETIC WAVE PROCESSING
[patent_app_type] => utility
[patent_app_number] => 16/470584
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470584
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/470584 | Method for efficiently producing 3D midbrain-like organoid through specific electromagnetic wave processing | Oct 31, 2017 | Issued |
Array
(
[id] => 12729733
[patent_doc_number] => 20180135078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => AAV-VECTORS FOR USE IN GENE THERAPY OF CHOROIDEREMIA
[patent_app_type] => utility
[patent_app_number] => 15/799852
[patent_app_country] => US
[patent_app_date] => 2017-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15799852
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/799852 | AAV-VECTORS FOR USE IN GENE THERAPY OF CHOROIDEREMIA | Oct 30, 2017 | Abandoned |
Array
(
[id] => 14831779
[patent_doc_number] => 20190274290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => GENETICALLY MODIFIED MOUSE MODEL FOR HUMAN HEPATOCYTE XENOTRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 16/345180
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345180
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345180 | GENETICALLY MODIFIED MOUSE MODEL FOR HUMAN HEPATOCYTE XENOTRANSPLANTATION | Oct 26, 2017 | Abandoned |
Array
(
[id] => 14360717
[patent_doc_number] => 10301646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Nuclease-mediated targeting with large targeting vectors
[patent_app_type] => utility
[patent_app_number] => 15/792112
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19033
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15792112
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/792112 | Nuclease-mediated targeting with large targeting vectors | Oct 23, 2017 | Issued |
Array
(
[id] => 12644853
[patent_doc_number] => 20180106782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => HIGH THROUGHPUT CARDIOTOXICITY SCREENING PLATFORM
[patent_app_type] => utility
[patent_app_number] => 15/784620
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15784620
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/784620 | HIGH THROUGHPUT CARDIOTOXICITY SCREENING PLATFORM | Oct 15, 2017 | Abandoned |
Array
(
[id] => 19106010
[patent_doc_number] => 11959095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Compositions, cell constructs, and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 16/341525
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 21057
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341525
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341525 | Compositions, cell constructs, and methods of making and using the same | Oct 12, 2017 | Issued |
Array
(
[id] => 12642096
[patent_doc_number] => 20180105863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => NEURAL STEM CELL THERAPY FOR OBESITY AND DIABETES
[patent_app_type] => utility
[patent_app_number] => 15/783100
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15783100
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/783100 | NEURAL STEM CELL THERAPY FOR OBESITY AND DIABETES | Oct 12, 2017 | Abandoned |
Array
(
[id] => 12625005
[patent_doc_number] => 20180100165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => RAAV-GUANYLATE CYCLASE COMPOSITIONS AND METHODS FOR TREATING LEBER'S CONGENITAL AMAUROSIS-1 (LCA1)
[patent_app_type] => utility
[patent_app_number] => 15/728628
[patent_app_country] => US
[patent_app_date] => 2017-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15728628
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/728628 | RAAV-GUANYLATE CYCLASE COMPOSITIONS AND METHODS FOR TREATING LEBER'S CONGENITAL AMAUROSIS-1 (LCA1) | Oct 9, 2017 | Abandoned |
Array
(
[id] => 13326137
[patent_doc_number] => 20180214606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => ORAL TISSUE REGENERATION AND REPAIR
[patent_app_type] => utility
[patent_app_number] => 15/698172
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698172
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698172 | ORAL TISSUE REGENERATION AND REPAIR | Sep 6, 2017 | Abandoned |
Array
(
[id] => 14501941
[patent_doc_number] => 20190194625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => BLOOD BRAIN BARRIER MODEL AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/322232
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322232 | Blood brain barrier model and methods of making and using the same | Aug 3, 2017 | Issued |
Array
(
[id] => 12056832
[patent_doc_number] => 20170333177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'BIOREACTOR SYSTEM AND METHOD OF ENHANCING FUNCTIONALITY OF MUSCLE CULTURED IN VITRO'
[patent_app_type] => utility
[patent_app_number] => 15/667986
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6145
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667986 | BIOREACTOR SYSTEM AND METHOD OF ENHANCING FUNCTIONALITY OF MUSCLE CULTURED IN VITRO | Aug 2, 2017 | Abandoned |
Array
(
[id] => 16399098
[patent_doc_number] => 20200339956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => BLOOD BRAIN BARRIER MODEL
[patent_app_type] => utility
[patent_app_number] => 16/321792
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321792 | BLOOD BRAIN BARRIER MODEL | Jul 30, 2017 | Pending |
Array
(
[id] => 17088629
[patent_doc_number] => 11116799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures
[patent_app_type] => utility
[patent_app_number] => 15/650595
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 18170
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/650595 | Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures | Jul 13, 2017 | Issued |
Array
(
[id] => 14747297
[patent_doc_number] => 20190256822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => HEPATIC CELL LINE RESISTANT TO DIMETHYL SULFOXIDE, CELL CULTURE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/312772
[patent_app_country] => US
[patent_app_date] => 2017-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312772 | HEPATIC CELL LINE RESISTANT TO DIMETHYL SULFOXIDE, CELL CULTURE AND USES THEREOF | Jun 30, 2017 | Abandoned |
Array
(
[id] => 12746533
[patent_doc_number] => 20180140678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => Directed Stem Cell Recruitment
[patent_app_type] => utility
[patent_app_number] => 15/640063
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15640063
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/640063 | Directed stem cell recruitment | Jun 29, 2017 | Issued |